维普中文期刊产品整合服务
71篇 您的检索式:作者名="De Fronzo"
    题名 作者 年代 出处 被引量
1Treatment of prediabetes显示文摘Progression of normal glucose tolerance(NGT) to overt diabetes is mediated by a transition state called impaired glucose tolerance(IGT). Beta cell dysfunction and insulin resistance are the main defects in type 2 diabetes mellitus(type 2 DM) and even normoglycemic IGT patients manifest these defects. Beta cell dysfunction and insulin resistance also contribute to the progression of IGT to type 2 DM. Improving insulin sensitivity and/or preserving functions of beta-cells can be a rational way to normalize the GT and to control transition of IGT to type 2 DM. Loosing weight, for example, improves whole body insulin sensitivity and preserves beta-cell function and its inhibitory effect on progression of IGT to type 2 DM had been proven. But interventions aiming weight loss usually not applicable in real life. Pharmacotherapy is another option to gain better insulin sensitivity and to maintain beta-cell function. In this review, two potential treatment options(lifestyle modification and pharmacologic agents) that limits the IGT-type 2 DM conversion in prediabetic subjects are discussed.Mustafa Kanat Ralph A De Fronzo Muhammad A Abdul-Ghani 2015World Journal of Diabetes2015,6,12:4
2Insulin resistance,lipotoxicity,type 2diabetes and atherosclerosis:the missing links显示文摘De Fronzo RA 2010Diabetologia2010,53,7:1
3Nephropathy in diabetes 显示文摘Mditch ME De Fronzo RA Franz MI 2004Diabetes Care2004,27,:1
4From the triumvirate to the ominous octet:a new paradigm for the treatment of type 2 diabetes mellitus 显示文摘De Fronzo RA 2009Diabe- tes2009,58,4:1
5Diabetic nephropathy显示文摘Molitch ME De Fronzo RA Franz MJ 2003Diabetes Care2003,26,1:1
6Insulin resistance hyperinsulinmia and coronary artery disease: a complex metabasis web显示文摘De Fronzo AR 1992Cardiovasc Pharmacol1992,11,:1
7The triumvirate: beta - cell, musele, liver, a collusion responsible for NIDDM显示文摘De Fronzo RA 1988Diabetes1988,37,6:1
8From the Triumvirate to the Ominous Octet:A New Paradigm for the Treatment of Type 2 Diabetes Metlitus显示文摘Ralph A De Fronzo 2009Diabetes2009,58,:1
9Effects of exenatide(exendin-4)on glycemie control and weight over 30 weeks in metformin-treated patients with type 2 diabetes显示文摘De Fronzo RA Ratner RE Han J 2005Diabet Care2005,28,:1
10Nephropathy in diabetes显示文摘Molitch M E De Fronzo R A Franz M J 2004DiabetesCare2004,27,11:1
11Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose显示文摘De Fronzo RA Abdul-Ghani M 2011Am J Cardiol2011,108,3:1
12A multifaced syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovasular disease 显示文摘De Fronzo RA Hames G R Taylor 1991Diabetes Care1991,14,:1
13Assessment and treatment of car- diovascular risk in prediabetes :impaired glucose tolerance and im- paired fasting glucose显示文摘De Fronzo RA Abdul-Ghani M 2011Am J Cardiol2011,108,3:1
14Insulin resistance:a multifaceted syndrome responsible for NIDDM,obesity,hypertension,dyslipidemia,and atherosclerotic cardiovascular disease显示文摘De Fronzo RA Ferrannini E 1991Diabetes Care1991,14,3:1
15A Multifaceted syndrome responsible for NIDDM,obesity,hypertension,dyslipidemia,and atheroscl-erosis cardiovascular disease显示文摘De Fronzo RA Ferranini E Insulin resisrance 1991Diabetes Care1991,14,3:1
16Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases 显示文摘Cersosimo E de Fronzo R A 2006Diabetes Metab Res Rev2006,22,6:1
17Insulin resistance,hyperinsulinemia and coronary artery disease:a complex metabolic web 显示文摘 1992J Cardiovasc Pharmacol1992,20,11:1
18A multifaced syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease显示文摘 Ferrannini E 1991Diabetes Care1991,14,:1
19Glucose clamp technique:a method for quantifying insulin secretion and resistance显示文摘De Fronzo R A Tobin J D Andres R 1979Am J Physiol1979,237,3:1
20Nephropathy in diabetes显示文摘Molitch ME De Fronzo RA Franz MJ 2004Diabetes Care2004,27,1:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费